A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer

In conclusion, this study with a limited number of patients, docetaxel + carboplatin concurrent with RT appears to show acceptable activity and is generally well tolerated in patients with locally advanced HNSCC.